Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.
暂无分享，去创建一个
M. André | K. van Eygen | W. Pluymers | D. Deeren | I. Abraham | M. Delforge | A. Ferrant | K. Theunissen | C. Graux | Y. Beguin | R. de Bock | K. MacDonald | D. Selleslag | A. V. D. Van de Velde | L. Noens | A. Harrington | F. Trullemans | A. Triffet | D. Breems | P. Mineur | A. Efira | W. Wynendaele | C. Ravoet | J. Lemmens | P. Pierre | D. Boulet | S. Van Steenweghen | Randal D'hondt | A. Deweweire | K. Geldhof